This Week in Nature

In this week's Nature Biotechnology, a University of Washington research team reports on a genomic approach for preventing the genetic side effects that have long been barriers to gene therapies. While gene therapies have been successfully developed for a number of diseases, insertional mutagenesis and genotoxicity, which usually manifest as a malignancy, hamper their widespread use.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.